A viral Facebook post with over 350,000 likes and 75,000 shares claims that scientists have developed a CRISPR-based therapy that removes HIV DNA from human cells and prevents the virus from returning.
Fact Check
This claim is misleading. While CRISPR research has made progress in laboratory experiments, no therapy has yet been proven to permanently remove HIV from the human body or to guarantee that the virus will not return.
What the Science Says
- Laboratory Research:
In 2024, researchers at Amsterdam University Medical Centre used CRISPR-Cas9 with two guide RNAs to cut HIV DNA out of CD4+ T cells in lab dishes. In those treated cells, the virus did not replicate immediately. However, this experiment was conducted outside the human body and does not reflect the complexity of HIV in living patients. - Human Trials:
The most advanced CRISPR therapy for HIV is EBT-101, developed by Excision BioTherapeutics, now in Phase 1/2 trials in the United States. Results so far show the treatment is generally safe. But when participants stopped their regular antiretroviral therapy (ART), the virus returned in all of them. One participant stayed virus-free longer than usual, but the suppression was temporary.
Why a Cure Remains Elusive
Experts identify several barriers before CRISPR could realistically cure HIV:
- Latent reservoirs: HIV hides in dormant cells that CRISPR cannot yet fully reach. These reservoirs can restart infection.
- Delivery challenges: Getting CRISPR safely into the right cells across the body is still a major technical obstacle.
- Viral diversity: HIV mutates quickly. CRISPR therapies that work on one viral strain may fail against others.
Verdict: Misleading
CRISPR has shown real promise in HIV research, and laboratory studies prove it can remove viral DNA from cells. Early human trials confirm the approach is safe, but no clinical evidence shows a cure or permanent prevention of viral rebound.
Conclusion:
The claim that HIV has been permanently erased from human cells is false. More research, better delivery systems, and larger clinical trials are required before CRISPR can be considered a cure for HIV.